Freenome logo

Freenome

Outpacing cancer starts with early detection

403 employees · est. 2014 · Brisbane, United States

VS
Marker X 銳準生醫 logo

Marker X 銳準生醫

Faster, more precise, and well in advance: Advocating preventative medicine towards early detection.

6 employees · est. 2020 · Taiwan

Freenome is the older company (2014 vs 2020); Freenome is the larger of the two.

Side-by-Side Comparison

Freenome Marker X 銳準生醫
Founded
2014 older 2020
Headquarters
Brisbane, United States Taiwan
Employees
403 larger 6
Industry
Biotechnology, Pharmaceutical Biotechnology
Funding Stage
Unknown Not tracked yet
Total Funding
$1.14B Not tracked yet
Funding Rounds
9 Not tracked yet
Services
Intelligent Screening Platform, Cancer Detection Tests, PREEMPT CRC Study, Blood-Based Diagnostics Not tracked yet
Target Customers
Healthcare Professionals, Medical Institutions, Patients at Risk for Cancer, Clinical Researchers Not tracked yet
Taxonomy
Biotech, Early Cancer Detection, Blood Tests, Multiomics, Colorectal Cancer, Advanced Adenomas, Non-invasive Testing, Disease Screening, Healthcare Innovation, Cancer Prevention, Cancer Treatment, Medical Technology, Patient Empowerment Biotech Company, Cancer Detection, Precision Medicine, Early Screening, Disease Biomarkers, Mass Spectrometry, Proteomic Methods, Companion Diagnostics, Chronic Disease Management, Early Intervention
Website
freenome.com marker-x.com
Freenome logo

About Freenome

Freenome, founded in 2014, is a rising star in the biotech sector headquartered in the United States. The company is dedicated to early cancer detection, aiming to empower individuals in the prevention, detection, and treatment of diseases. Their slogan, "Outpacing cancer starts with early detection...

Marker X 銳準生醫 logo

About Marker X 銳準生醫

Marker Exploration Corporation (Marker X) is a biotech startup founded in 2020 with a focus on discovering novel disease biomarkers. Their slogan "Discovering Tomorrow's Health, Today: Precision Screening for Early Cancer Detection and Chronic Disease Management" epitomizes their mission. Using adva...

We will tell you when either one moves

BounceWatch watches Freenome and Marker X 銳準生醫 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Freenome and Marker X 銳準生醫 — by email.

Frequently Asked Questions

Freenome — Outpacing cancer starts with early detection. Marker X 銳準生醫 — Faster, more precise, and well in advance: Advocating preventative medicine towards early detection.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Freenome has raised $1.14B while Marker X 銳準生醫 has raised undisclosed funding.
Freenome and Marker X 銳準生醫 operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Freenome with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Freenome on 9 Jun 2026, and Marker X 銳準生醫 on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy